Natera Announces Commercial Launch of Zenith™ Genomics for Rare Disease Diagnosis
Go back to Natera Announces Commercial Launch of Zenith™ Genomics for Rare Disease Diagnosis| (NASDAQ: NTRA) | Delayed: 279.32 +3.05 (1.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $276.27 | 52 Week High | $13.80 | |||
| Open | $278.47 | 52 Week Low | $6.52 | |||
| Day High | $279.63 | P/E | N/A | |||
| Day Low | $271.64 | EPS | $0.00 | |||
| Volume | 1,274,248 | |||||
